跳至主要内容
临床试验/JPRN-UMIN000035188
JPRN-UMIN000035188招募中未知

Multicenter, prospective research on prevalence and fibrosis stage distribution in Japanese NAFLD patients using with ultrasound elastography [FibroScan] and Fib4 index - Multicenter, prospective research on prevalence and fibrosis stage distribution in Japanese NAFLD patients using with ultrasound elastography [FibroScan] and Fib4 index

Yokohama City University0 个研究点目标入组 10,000 人开始时间: 2018年12月9日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
10,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Alcohol consumption (ethanol equivalent volume), >=30 g/day for men, >=20 g/day for women, or >=210 g/day for men, >=140 g/day for women. 2. History of chronic hepatic disease (hemochromatosis, viral hepatic disease [hepatitis B or C], or autoimmune disease,[autoimmune hepatitis, primary biliary cholangitis]), thyroid disorder, lipoatrophy, parenteral nutrition, abetalipoproteinemia, alpha-1-antitrypsin deficiency, Wilson's disease, antiretroviral therapy, Reye's syndrome, HELLP syndrome, or inborn errors of metabolism (lecithin-cholesterol acyltransferase deficiency or lysosomal acid lipase deficiency) 3. Drug-induced liver disorder (amiodarone, methotrexate, tamoxifen, corticosteroids, valproic acid, and antiretroviral drugs)

研究者

相似试验